Background: Guillain-Barré syndrome (GBS) is a rare, autoimmune-mediated disease. The use of Bifidobacterium is reportedly effective in alleviating GBS since they act by regulating T helper (Th) cells. Objectives: In this study, we explored the differentiation of T helper cell subsets in patients with GBS. We also evaluated the effect of GBS on Bifidobacterium levels in patients and the likely protective influence of this bacterium in alleviating the disease in an animal model. Materials and methods: We used flow cytometry, and real-time polymerase chain reaction (PCR) to determine the T cell subsets differentiation among 30 GBS patients and 20 healthy controls (HC). The concentration of Bifidobacterium was assayed by real-time PCR. Experimental autoimmune neuritis (EAN) animal model was established to support the protective role of Bifidobacterium in GBS. Results: The expression of Th cells, Th2 and Th17 in the patients was significantly higher than that in the HC, while Treg cells decreased substantially. Moreover, the levels of Bifidobacterium in the GBS patients were considerably lower than those in the HC, the concentration of Bifidobacterium correlating with Th2 and Th17 subsets negatively. Treatment with Bifidobacterium significantly reduced the levels of Th2 and Th17 and promoted the levels of Treg cells. Conclusions: We concluded from this study that Bifidobacterium alleviated GBS by regulating Th cells, although in-depth studies might be required to fully understand the mechanism of action.
Introduction
Guillain-Barré syndrome (GBS) is an acute and inflammatory autoimmune polyneuropathy that affects the nerve roots and at times in conjunction with peripheral nerves. The disease is one of the most severe instigators of acute symmetric flaccid paralysis worldwide, which is the leading cause of sudden neurological injury [1] , with high disability and mortality incidences, mostly in young adults. 10% of GBS patients have acute sequelae, and about 5% of them die of respiratory failure, lung infections, and other complications. Plasmapheresis, intravenous human immunoglobulin, and other immunotherapies do not provide satisfactory treatments, and there have been no adequate measures to block the development of the disease till now. There is an approximate increase of 0.1 million GBS cases in China every year, bringing enormous financial and psychological burdens to the families and the society. So, it is of immense importance to investigate its pathogenesis and to develop more effective treatment approaches for improving the patients' quality of life and for reducing social burden.
Studies on immunological mechanisms of GBS have shown that CD4 + T cell subsets (also known as Th cells) including Th1, Th2, Th17, and CD4 + CD25 + T cells (Treg) and other immune effector cells and cytokines, such as interleukins (IL), interferons (IFN), and tumor necrosis factors (TNF) form complicated linkages involved in the immunoregulation of GBS. These linkages purportedly influence the occurrence, development, and prognosis of the disease [2, 3] . Meanwhile, reports suggest that the expression of Th17 cell-related cytokines in the peripheral blood and cerebrospinal fluid of patients with GBS increases and that of the Treg cells decreases. With different post-immunotherapy results, the mechanism of action of Th cell subsets on autoimmunity and peripheral myelin insulation damage remains unclear. Further studies are, therefore, needed. Recent molecular biology and immunology evaluations have found that probiotics have significant effects on human health [4] . There is growing evidence to support the claim that probiotics activate and modulate host immune systems through the intestinal immune system, and inhibit abnormal autoimmune responses, playing an essential role in the treatment of abdominal and other autoimmune diseases characterized by inflammation, such as Crohn's disease, etc. [5] . Also, in vitro, and in vivo studies revealed that Bifidobacterium infantis (B. infantis), one of the critical probiotics in the intestinal tract, has an undeniable influence on the differentiation of Th cell subsets [6] . Gastrointestinal perfusion with B. infantis could improve the imbalance of increased expression of Th17 cell-related factors and decreased expression in the level of Treg cells in the peripheral blood in rat models with inflammatory bowel diseases [7] . We showed, in our previous work, that the unbalanced expression and the rebalancing of Th cell subsets (Th1, Th2, Th17) and Treg cells play a crucial role in the damage and repair of GBS. Subsequently gastrointestinal perfusion with a quantitative B. infantis was proven to change the disproportion of Th cell subsets in peripheral blood lymphocytes and increase their autoimmune inflammatory responses. It has been proposed that there are many different Th cell subsets which may contain different functional subsets (for neuroprotection and nerve impairment) in the local or systemic microenvironment before and after the onset of GBS, but the mechanism is still unknown.
In the present study, we explored the correlation between the differentiation, imbalanced expression of Th cells, and the pathogenesis and clinical symptoms of GBS and observed the effect of B. infantis in improving the imbalance of Th subsets, thereby ameliorating GBS symptoms. We studied the role of Th subset differentiation in the occurrence and development of GBS in humans and investigated the efficacy of gastrointestinal-infused B. infantis on GBS in a rat model.
Materials and methods

Subjects
All patients with GBS who accepted medical services in the First Affiliated Hospital of Bengbu Medical College from January 2017 to December 2018, 30 patients in all, were enrolled in this study. The patients were diagnosed according to the National Institute of Neurological Disorders and Stroke (NINDS) diagnostic criteria [8] . All cases fell into two categories: acute inflammatory demyelinating polyneuropathy (AIDP) and acute motor axonal neuropathy (AMAN). Acute motor-sensory axonal neuropathy (AMSAN), Miller-Fisher syndrome, and chronic inflammatory demyelinating peripheral neuropathy (CIDP) were excluded. Experienced neurologists evaluated the severity of individual patients with GBS using the GBS disability scale scores (GDSS). Scores were graded 0 -regular neurological status; grade 1 -minor symptoms, able to run; grade 2 -limb weakness, able to walk 5 m unaided; grade 3 -able to walk 5 m only with aid; grade 4 -chair-or bed-bound; grade 5 -requiring assisted ventilation; and grade 6 -death. Written informed consent was obtained from individual participants, and the experimental protocol was approved by the Ethical Committee of Bengbu Medical College. Their demographic and clinical characteristics are summarized in Table 1 . Individual patients were treated daily with the intravenous administration of 0.4 g/kg/d of immunoglobulin for 7 consecutive days.
Detection of Th1, Th2, Th17 and Treg cells by flow cytometry
We obtained informed consent from all subjects before blood collection. Peripheral blood samples were collected from all the patients directly into containers, as were control samples. The blood collected was diluted at a ratio of 1:1 with an equivalent volume of PBS and a 1:1 ratio of an appropriate amount of human lymphocyte separation medium (Haoyang, Tianjing, China) was taken according to the amount of the blood sample with anticoagulants and added to a 15 mL centrifuge tube. After a 20 min centrifugation at 1500 rpm, the white blood cells, which formed a white film-like layer under the supernatant, were collected and pippeted into a sterile centrifuge tube and centrifuged at 10000 rpm for 5 min. Following a 3-time wash, the total cell number and the percentage of living cells were counted using the trypan blue staining.
The cells ( , representing the Th1, Th2, Th17 and Treg cells, respectively, were determined by flow cytometry. Data analysis was conducted using CELLQUEST or Win MDI software. A minimum of 30,000 cells was counted for each sample, and specific homologous control antibodies were used for eliminating the nonspecific staining.
The detection of B. infantis by real-time polymerase chain reaction (PCR)
Two gram of fresh stool were thoroughly mixed with 18 mL PBS and centrifuged at 400 ×g for 5 min. The top content of the centrifuged mixture was collected and thrice centrifuged at 400 g for 5 min. 1 mL of the upper portion of the second centrifuged mixture was collected and centrifuged at 9000 g for 3 min, washed 4 times with PBS, and redissolved in 0.1 mL distilled water. After a 5 min heating at 100°C, the cells were immediately placed in ice water.
A pure culture of B. infantis (10 2 -10 8 CFU/mL) was used as a positive template, and its fluorescence curve was used as a standard curve. The primers used for B. infantis were 5′-CTCCTGGAAACGGGTGG-3′ and 5′-GGTGTTCTTCCCGATATCTACA-3′. Real-time PCR was carried out at 95°C for 15 s, followed by 40 cycles each of 94°C for 10 s, 55°C for 10 s, 74°C for 35 s, and then 74°C for 2 min.
Detection of transcription factors by real-time PCR
Total RNA from lymphocytes (10 6 cells) was extracted using Trizol (Invitrogen, CA, USA) and reverse transcription was carried out with a Reverse Transcriptase kit (Takara, Dalian, China). Real-time PCR was performed with the following primers: T-bet (sense 5′-GGACCCAACT GTCAACTGC-3′, anti-sense 5′-TGTCGCCACTGGAAGGA-3′); GATA-3 (sense 5′-GCCATTCGTACATGGAAGC-3′, anti-sense 5′-CGGAGGGTAA ACGGACAG AG-3′); RORγτ (sense 5′-GCAGCAACAGGAACAAGTGG-3′, anti-sense 5′-GCTTTGCCTCGTTCTGGACT-3′), Foxp3 (sense 5′-GCAGC AACAGGAACAAGTGG-3′, anti-sense 5′-GCTTTGCCTCGTTCTGG ACT-3′), and β-actin (sense 5′-GTGGACATCCGCAAAGAC-3′, anti-sense 5′-AAAGGGTGTAACGCAACTAA-3′). PCR was run in a 7300 real-time PCR System (Applied Biosystems, CA, USA) using a general SYBR green fluorescence detection for 10 min at 94°C, followed by 45 cycles each of 15 s at 95°C, 30 s at 60°C, and 30 s at 72°C. The calculation of relative quantitative expression was done using 2 −ΔΔCT method [9] . 
Establishment of experimental autoimmune neuritis (EAN) in a rat model
Each rat was injected under the plantar surface of the hind paws with a total of 100 μl sensitizing agents, including 250 μg of P2 53-78 emulsified with an equivalent amount of Complete Freund's Adjuvant (Sigma, MO, USA, comprising 10 mg/mL M. Tuberculosis H37Ra). 200 ng of pertussis toxin was given to each rat by caudal vein injection on Day 0 (the day the sensitization was established) and 24 h after the sensitization. Assessment of clinical symptoms of paralysis for the rats in the sensitized and healthy groups was conducted, and GDSS scores and changes in body weight were recorded daily by two laboratory technicians, from Day 0 to Day 30 after sensitization. Spies' EAN scoring standards [10] : 0 -no abnormalities; 1 -tail tension reduced and tail tip pointed up; 2 -tail paralysis and partial loss of the righting reflex; 3 -loss of the righting reflex; 4 -abnormal posture and gait; and 5 -hindlimb paralysis. On day 15 post-sensitization, general anesthesia was administered to one rat from each group, and the bilateral sciatic nerves were obtained surgically and fixed in 2.5% Glutaraldehyde and examined by electron microscopy to observe whether there was demyelination of the myelin sheath and axonal degeneration and injury.
B. infantis intervention
The 15 EAN model rats were divided into three groups and were injected with either normal saline, low-concentration B. infantis 
Statistical analysis
Statistical comparisons among different groups were made using the Student t-test and one-way analysis of variance (ANOVA) using SPSS 18.0 software, followed by Duncan's multiple range tests. Pearson correlation coefficients were used to establish relationships between variables. A two-sided p value of < 0.05 was considered statistically significant. 
Results
Demographic and clinical characteristics of study subjects
Thirty GBS patients and twenty HC were recruited. Table 1 contains their demographic and clinical characteristics. There was no significant difference in the distribution of age and gender between the GBS patients and the HC. Moreover, there was no substantial variation in the values of Albumin in the plasma and WBC in the CFS, and plasma between the GBS patients and the HC; however, the concentrations of albumin in the CSF patients were significantly higher than those in the HC (p < 0.01).
Th2 and Th17 cells increased while Treg cells decreased in patients with GBS
To investigate the differentiation of Th cells, we examined the expression of Th subsets in 30 patients with GBS and 20 HC by flow cytometry. We found that the positive cells of Th2 and Th17 cells in the patients were significantly higher than those in the HC, while Treg cells decreased massively (Fig. 1, p < 0.05) .
To further verify the differentiation of Th cells, the mRNA levels of transcription factors were examined using Real-time PCR. The results showed that the mRNA expression of GATA-3 and RORγτ in the patients were remarkably higher than those in the HC (Fig. 2) .
B. infantis decreased in patients with GBS
Next, we detected the levels of B. infantis in the stool samples by using real-time PCR. The results revealed that the levels of B. infantis in the GBS patients were significantly lower than those in the HC (Fig. 3A , p < 0.01). Further analysis demonstrated that the mRNA expression levels of GATA-3 and RORγτ correlated negatively with the concentrations of B. infantis (Fig. 3B , r = −0.5866 and p = 0.0279; r = −0.4259 and p = 0.0341, respectively). On the other hand, there was no correlation between mRNA expression level of Foxp3 and the concentrations of B. infantis (r = 0.234, p = 0.057). These data would seem to suggest that the augmented levels of Th2 and Th17 and the decreased concentration of B. infantis may be associated with the development of GBS.
B. infantis improved symptoms of EAN animal models
Two weeks after B. infantis administration, we found, through the examination of TEM, that the ultrastructure of the sciatic nerves changed, including swelling, disorganization, and separation of the myelin lamellae (Fig. 4A) . We also noticed an attenuation of the peripheral nerve demyelination after the administration of B. infantis, (Fig. 4A) . Moreover, B. infantis administration promoted the conduction velocity and amplitude of sciatic nerves (Fig. 4B, p < 0.05 ). There were no differences between low and high concentrations. Therefore, B. infantis can efficiently improve the symptoms of EAN in our rat model.
B. infantis reduced the levels of Th2 and Th17 cells
Two weeks after the B. infantis treatment, we realized that the positive cells of Th2 and Th17 cells in B. infantis groups were significantly lower than those in the model group, while there was no substantial alteration in the levels of Th1 cells (Fig. 5) . There was also no remarkable modification between the low and high concentrations of B. infantis. Therefore, the B. infantis administration potentially reduced the levels of Th2 and Th17 and promoted the level of Treg cells in the EAN animal models.
Discussion
GBS, an acute autoimmune polyneuropathy affecting the nerve roots and/or peripheral nerves, is one of the most common causes of acute symmetric flaccid paralysis worldwide and is the primary cause of sudden neurological injury. Clinical symptoms are characterized by rapid, progressive and symmetric flaccid paralysis of the extremities, with or without the signs of autonomic nerve damage or cranial nerve palsy, with or without sensory disorders. Patients with such clinical manifestations show the most significant weakness within the first two weeks of the onset of the disease, which may involve the respiratory muscles; a support breathing assisted respiration equipment usually required in severe situations. Characteristic high protein level and low cell counts in the CSF appear within 10-14 days. The most common types of GBS are AIDP, AMAN, AMSAN, Miller-Fisher syndrome, acute autonomic neuropathy, and severe sensory neuropathy.
Th cells, as the main components of T lymphocytes, are closely related to GBS processes of injury and repair. According to different types + foxp3 + [14] . Studies established that Th1/Th17 were "pro-inflammatory cells," mediating a nonspecific inflammatory response and Treg/Th2 cells were "anti-inflammatory cells," mediating immune tolerance, while a mutual antagonist existed in the two types of cells in terms of differentiation process and functioning. Balance in these cells is conducive to maintaining the body's stable immune state. The imbalance between Th1/Th2 and Th17/Treg cells may lead to many chronic inflammatory diseases, autoimmune diseases, and tumors [15, 16] . In this study, we noticed that, during the acute stage of GBS, the levels of Th2 and Th17 cells increased significantly and that of the Treg cells decreased. At the same time, the levels of Bifidobacterium in the GBS patients were substantially lower than those in the HC, and the concentration of Bifidobacterium correlated negatively with Th2 and Th17 subsets, suggesting that Th2 and Th17 induce an autoimmune response in GBS, associated with decreased Bifidobacterium.
Recent studies have demonstrated that adequate intestinal probiotics have an essential impact on the health of the human beings. Subsequently, more attention is drawn to this facet. B. infantis, one of the most necessary and universal probiotics in the intestinal tract, has been proven to play a crucial role in the treatment of autoimmune diseases, such as Crohn disease. The results of this study showed that B. infantis downregulated Th2 and Th17 and promoted the differentiation of Treg cells. Through the evaluation of the gut symbiotic bacteria in mice, a report revealed that an increase in the level of intestinal Bifidobacterium could alleviate the symptoms of Th17-mediated autoimmune inflammatory bowel diseases, such as abdominal mucosal lesions, diarrhea and weight loss [7] . To further explore the mechanisms of combined actions between specific flora and IL-17A secreting cells and costimulating molecules in the intestinal epithelial cells, supernatant from Bifidobacterium was given to the model mice of DSS colitis by gastric infusion [17] . Suit to this, downregulations were registered in the expression of cytokines in the Th17 cells and the costimulating molecules of the colonic epithelial cells. Our investigations, therefore, confirm that Bifidobacterium had an inhibiting effect on IL-17 cell secretion and could promote Treg/Th17 balance.
In conclusion, Th cell subsets are closely associated with the onset of GBS and the presence of Bifidobacterium can efficiently improve the imbalance of Th subsets. These findings may provide a new strategy for the treatment of GBS. 
